Stocks making the biggest moves after hours: Oracle, Chewy, Lululemon and more

Market Insider

The Oracle logo is displayed on the exterior of Oracle headquarters on December 09, 2021 in Redwood Shores, California.
Justin Sullivan | Getty Images

Check out the companies making headlines in after-hours trading.

Oracle — Shares of Oracle jumped 6.5% after reporting earnings and revenue beats for its fiscal second-quarter. Oracle brought in $1.21 per share in earnings, beating estimates by 10 cents, and $10.36 billion in revenue, topping estimates of $10.21 billion.

Broadcom — Broadcom’s shares rose more than 5% after the semiconductor company released its quarterly results. Broadcom reported a profit of $7.81 per share, compared with estimates of $7.74 per share. Revenue for the quarter came in at $7.41 billion, above estimates of $7.36 billion.

Lululemon — The athleisure apparel maker reported a beat on quarterly earnings and a slight beat on revenue. The company reported earnings of $1.62 per share, beating estimates by 21 cents, according to Refinitiv. It recorded quarterly revenue of $1.45 billion versus estimates of $1.44 billion.

Costco — Shares of Costco gained more than 1% after reporting earnings of $2.98 per share and a revenue beat for its most recent quarter. The company also reported a 15% jump in comparable sales and a 14.3% increase in e-commerce sales.

Chewy Chewy shares fell about 8% after the pet company reported a wider-than-expected loss of 8 cents per share for the most recent quarter, citing supply chain disruptions, labor shortages and higher inflation. Revenue came in as expected at $2.21 billion for the quarter. However, the company also reported a miss on new customer additions.

Articles You May Like

Point72’s Steve Cohen is stepping back from trading his own book
Rate Cuts to Energize Markets, Score Investors Tremendous Profits
Rate Cuts: Entering a New Era of Explosive Stock Gains
The Fed Just Opened a Door to Stunning Stock Gains
Op-ed: Here’s why a sale of Bausch + Lomb could lead to a windfall for Bausch Health investors